Skip to content

PharmaCyte Biotech, Inc.

Reporting owner on Forms 3, 4 and 5, CIK 1157075.

PharmaCyte Biotech, Inc. reported on 1 issuer in 2 filings, the latest a 13D/A filed 2026-11-20.

Issuers

IssuerRoles in the latest filingFilingsLast filed
QCLS · Q/C TECHNOLOGIES, INC.CIK 132183410% owner12026-11-20

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
QCLS · Q/C TECHNOLOGIES, INC.Common stock2026-11-18X exercised+4,982,272$05,152,000Form 4
QCLS · Q/C TECHNOLOGIES, INC.Series G Long-Term Warrants, derivative2026-11-18X exercised-851,304$013,318,344Form 4
QCLS · Q/C TECHNOLOGIES, INC.Series H Convertible Preferred Stock, derivative2026-11-18J other+3,000$03,000Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13D/A 0001683168-26-009020 QCLS2026-11-20
Form 4 0001683168-26-009018 Q/C TECHNOLOGIES, INC.2026-11-20